NDC 75907-215 - SRONYX
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 75907-215
- Manufacturer
- Dr. Reddy's Labratories Inc.
- Effective date
- 2024-09-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SRONYX ® (Levonorgestrel and Ethinyl Estradiol Tablets USP) | Dr. Reddy's Labratories Inc. | 2024-09-20 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Next Choice One Dose | LEVONORGESTREL | Foundation Consumer Healthcare LLC | 504735bd-6af9-4588-bf85-d09dbf2a7e41 | 2023-02-02 | Warnings | 5W7SIA7YZW |
| Take Action | LEVONORGESTREL | Foundation Consumer Healthcare LLC | 78eee7c9-5ca5-45af-898f-92a2f3b2598e | 2023-01-31 | Warnings | 5W7SIA7YZW |
| Aftera | LEVONORGESTREL | Foundation Consumer Healthcare LLC | 53ad8dff-9134-475c-90b3-8087753e17c4 | 2023-01-31 | Warnings | 5W7SIA7YZW |
| Plan B One-Step | LEVONORGESTREL | Foundation Consumer Healthcare LLC | 6ce6b40e-14ac-47bd-a648-ddf9e452e559 | 2023-01-31 | Warnings | 5W7SIA7YZW |
| Opcicon One-Step | LEVONORGESTREL | Sun Pharmaceutical Industries, Inc. | b67ca313-561e-471f-baf3-257b7e253c75 | 2023-01-13 | Warnings | 5W7SIA7YZW |
| Morning After | LEVONORGESTREL | Rapha Pharmaceuticals, Inc. | f0fab784-3d28-35fb-e053-2995a90ab611 | 2022-12-29 | Warnings | 5W7SIA7YZW |
| Etonogestrel and Ethinyl Estradiol | ETONOGESTREL AND ETHINYL ESTRADIOL | Teva Pharmaceuticals USA, Inc. | a8cc104a-d522-49ad-af54-2f312b829b61 | 2022-09-30 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Optionelle | LEVONORGESTREL TABLET, 1.5 MG | Strides Pharma Inc | 1c7e849c-6392-48a6-9214-907325a012e2 | 2022-09-16 | Warnings | 5W7SIA7YZW |
| Levonorgestrel Tablet, 1.5 mg | LEVONORGESTREL TABLET, 1.5 MG | Strides Pharma Inc | 98f6367e-14d2-4c7a-9418-d996f0040d22 | 2022-09-13 | Warnings | 5W7SIA7YZW |
| My Choice TM | LEVONORGESTREL | Proficient Rx LP | 165f7270-d050-4e97-b30f-107b96940d84 | 2022-09-01 | Warnings | 5W7SIA7YZW |
| ZAFEMY | NORELGESTROMIN AND ETHINYL ESTRADIOL | Amneal Pharmaceuticals LLC | 5ee34c07-65af-42b8-a98f-e299ff90a8a1 | 2022-04-30 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| My Choice TM | LEVONORGESTREL | SUN PHARMACEUTICAL INDUSTRIES, INC. | 66753300-fb61-4f09-af74-ee498b0bd595 | 2022-04-21 | Warnings | 5W7SIA7YZW |
| Norelgestromin and Ethinly Estradiol | NORELGESTROMIN AND ETHINLY ESTRADIOL | Amneal Pharmaceuticals NY LLC | 36445b6a-e0f2-42f7-a8f3-5b80c90b87dd | 2022-03-30 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| XULANE | NORELGESTROMIN AND ETHINYL ESTRADIOL | Mylan Pharmaceuticals Inc. | f7848550-086a-43d8-8ae5-047f4b9e4382 | 2022-03-04 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Amethyst | LEVONORGESTREL AND ETHINYL ESTRADIOL | Teva Pharmaceuticals, Inc. | 99073fe0-eac8-44dd-abe6-623fa67d9e79 | 2022-01-31 | Warnings, Adverse reactions | 423D2T571U 5W7SIA7YZW |
| Nortrel 28 Day | NORETHINDRONE AND ETHINYL ESTRADIOL | Teva Pharmaceuticals USA, Inc. | 140c50d6-c931-423a-9aa0-526eae7ab93c | 2021-12-01 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Option 2 | LEVONORGESTREL | L. Perrigo Company | 9b9e9352-3e4d-4ec3-96aa-8fd58d82fe96 | 2020-07-30 | Warnings | 5W7SIA7YZW |
| AfterPlan | LEVONORGESTREL | SUN PHARMACEUTICAL INDUSTRIES, INC. | c30c7bc2-04fa-4590-96f5-5bcf4bba3f1a | 2018-10-26 | Warnings | 5W7SIA7YZW |
| Morning After | LEVONORGESTREL | Rapha Pharmaceuticals, Inc. | 677aa953-3c30-4ce5-e053-2991aa0ab2b2 | 2018-03-15 | Warnings | 5W7SIA7YZW |
| Levonorgestrel | LEVONORGESTREL | Novel Laboratories, Inc. | ac13a073-a33a-45f7-8483-eecc9190195f | 2017-09-15 | 5W7SIA7YZW |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.